Clinical trials: Pre-emptive Pharmacogenomics
Pre-emptive Pharmacogenomics
Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)
In collaboration with Raffles Medical Group, we will be recruiting 500 patients and following them for the next 3-12 months to see whether pharmacogenomics information provided in the Raffles' Electronic Health Records (EHR) will…
- Trial name
- NCT05504135
- Testing
- Pharmacogenomics Testing
- Where
- Singapore
- Volunteers
- 222 people
- Sponsor
- Nalagenetics Pte Ltd